Sio Capital Management, LLC — 13F Holdings & Portfolio

CIK 1482416 · latest 13F-HR filed 2026-08-14

Sio Capital Management, LLC manages $604.3M in 13F-reported U.S. long-equity assets across 59 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are AVR (9.04%), COR (8.13%), MMS (6.36%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 15 new positions and exited 31; 14 existing positions rose in reported value and 23 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$604.3M

Long-equity book

Holdings
59

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+15 / −31 / ↑14 / ↓23

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 50.1%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

As of the firm’s regulatory filing dated Mar 18, 2026.

Assets Under Management
$1.29B
Discretionary
$1.29B
Employees
13
Accounts
6
Address
600 THIRD AVENUE
2ND FLOOR
NEW YORK, NY 10016
Phone
(212) 601-9792
Name Title / Status Ownership Type
CASTOR, MICHAEL, BERNARD ControlMANAGING MEMBER
since Mar 2006
75% or moreIndividual
DRILLICK, JUDAH, ZVI ControlCHIEF EXECUTIVE OFFICER
since Jul 2015
Less than 5%Individual
LEE, JIN, WOO ControlCHIEF COMPLIANCE OFFICER
since Feb 2021
Less than 5%Individual
Ownership & leadership changes · 7 filings with changes since Apr 26, 2013

From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.

Mar 7, 2022 filing
  • No longer listedVIGNEAU, ALBERT, CHARLES · PARTNER · Less than 5% · control person · listed since Mar 2011
Feb 16, 2021 filing
  • AddedLEE, JIN, WOO · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ChangedDRILLICK, JUDAH, ZVI · title CHIEF EXECUTIVE OFFICER AND CHIEF COMPLIANCE OFFICER → CHIEF EXECUTIVE OFFICER
Jan 13, 2021 filing
  • ChangedDRILLICK, JUDAH, ZVI · title CHIEF COMPLIANCE OFFICER AND CHIEF FINANCIAL OFFICER → CHIEF EXECUTIVE OFFICER AND CHIEF COMPLIANCE OFFICER
Mar 15, 2019 filing
  • ChangedDRILLICK, JUDAH, ZVI · title CHIEF COMPLIANCE OFFICER → CHIEF COMPLIANCE OFFICER AND CHIEF FINANCIAL OFFICER
  • ChangedVIGNEAU, ALBERT, CHARLES · title CHIEF FINANCIAL OFFICER → PARTNER
Jul 21, 2015 filing
  • AddedDRILLICK, JUDAH, ZVI · CHIEF COMPLIANCE OFFICER · Less than 5% · control person
  • ChangedVIGNEAU, ALBERT, CHARLES · title CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER → CHIEF FINANCIAL OFFICER
Aug 27, 2014 filing
  • ChangedCASTOR, MICHAEL, BERNARD · title MANAGING MEMBER OF THE ADVISER AND THE GP → MANAGING MEMBER
  • ChangedVIGNEAU, ALBERT, CHARLES · title CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER OF THE ADVISER AND THE GP → CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER
Mar 22, 2014 filing
  • ChangedCASTOR, MICHAEL, BERNARD · title MANAGING MEMBER → MANAGING MEMBER OF THE ADVISER AND THE GP
  • ChangedVIGNEAU, ALBERT, CHARLES · title CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER → CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER OF THE ADVISER AND THE GP
Apr 26, 2013 filing (earliest on record)
  • ListedCASTOR, MICHAEL, BERNARD · MANAGING MEMBER · 75% or more · control person
  • ListedVIGNEAU, ALBERT, CHARLES · CHIEF FINANCIAL OFFICER AND CHIEF COMPLIANCE OFFICER · Less than 5% · control person

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Sio Capital Management, LLC Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 ANTERIS TECHNOLOGIES GLOBAL AVR 03675P102 $54.6M 9.04% 5,545,984 SH
2 CENCORA INC COR 03073E105 $49.1M 8.13% 173,588 SH
3 MAXIMUS INC MMS 577933104 $38.5M 6.36% 715,267 SH
4 ALLOGENE THERAPEUTICS INC ALLO 019770106 $27.7M 4.59% 13,323,431 SH
5 GLOBUS MED INC GMED 379577208 $23.8M 3.95% 301,816 SH
6 GSK PLC GSK 37733W204 $22.9M 3.79% 436,700 SH
7 TYRA BIOSCIENCES INC TYRA 90240B106 $22.2M 3.68% 695,315 SH
8 WAYSTAR HLDG CORP WAY 946784105 $19.0M 3.15% 925,834 SH
9 SELLAS LIFE SCIENCES GROUP I Put SLS 81642T209 $18.2M 3.01% 1,230,700 SH
10 IDEAYA BIOSCIENCES INC IDYA 45166A102 $17.9M 2.96% 480,383 SH
11 ORUKA THERAPEUTICS INC ORKA 687604108 $16.9M 2.79% 177,118 SH
12 THE CIGNA GROUP CI 125523100 $15.9M 2.63% 57,750 SH
13 SANOFI SA SNY 80105N105 $15.5M 2.57% 364,200 SH
14 ICON PUB LTD CO ICLR G4705A100 $15.3M 2.53% 88,186 SH
15 VIATRIS INC VTRS 92556V106 $15.2M 2.51% 954,299 SH
16 CROSS CTRY HEALTHCARE INC CCRN 227483104 $14.5M 2.40% 1,098,393 SH
17 RAPPORT THERAPEUTICS INC RAPP 75383L102 $12.8M 2.12% 307,657 SH
18 ABBOTT LABORATORIES ABT 002824100 $11.7M 1.93% 128,656 SH
19 CELCUITY INC CELC 15102K100 $11.5M 1.90% 110,022 SH
20 ZIMMER BIOMET HOLDINGS INC ZBH 98956P102 $11.3M 1.87% 131,445 SH
21 REGENERON PHARMACEUTICALS REGN 75886F107 $11.2M 1.86% 18,000 SH
22 BRISTOL-MYERS SQUIBB CO BMY 110122108 $11.1M 1.85% 193,500 SH
23 MEDTRONIC PLC MDT G5960L103 $11.1M 1.84% 142,500 SH
24 VIR BIOTECHNOLOGY INC VIR 92764N102 $11.0M 1.81% 1,075,274 SH
25 SENSEONICS HLDGS INC SENS 81727U303 $9.0M 1.50% 1,592,692 SH
26 EYEPOINT INC EYPT 30233G209 $8.9M 1.47% 623,130 SH
27 CYBIN INC HELP 23256X407 $8.6M 1.42% 1,300,000 SH
28 ANI PHARMACEUTICALS INC ANIP 00182C103 $8.1M 1.33% 97,305 SH
29 PROTARA THERAPEUTICS INC TARA 74365U107 $7.3M 1.21% 1,921,872 SH
30 RELMADA THERAPEUTICS INC RLMD 75955J402 $6.9M 1.15% 1,003,562 SH
31 TANGO THERAPEUTICS INC TNGX 87583X109 $6.5M 1.08% 208,500 SH
32 AQUESTIVE THERAPEUTICS INC AQST 03843E104 $6.2M 1.02% 1,486,175 SH
33 DIANTHUS THERAPEUTICS INC DNTH 252828108 $5.8M 0.96% 59,254 SH
34 SIONNA THERAPEUTICS INC SION 829401108 $5.6M 0.93% 127,808 SH
35 OCULAR THERAPEUTIX INC OCUL 67576A100 $5.3M 0.88% 539,493 SH
36 ZENAS BIOPHARMA INC ZBIO 98937L105 $5.3M 0.88% 208,557 SH
37 BRIGHT MINDS BIOSCIENCES INC DRUG 10919W405 $5.2M 0.86% 73,952 SH
38 ONKURE THERAPEUTICS INC OKUR 68277Q105 $4.9M 0.81% 1,078,965 SH
39 SAVARA INC SVRA 805111101 $3.8M 0.63% 617,675 SH
40 PMV PHARMACEUTICALS INC PMVP 69353Y103 $3.5M 0.58% 2,634,137 SH
41 AVEANNA HEALTHCARE HLDGS INC AVAH 05356F105 $3.2M 0.52% 369,036 SH
42 OVID THERAPEUTICS INC OVID 690469101 $2.7M 0.45% 1,005,334 SH
43 IMMUNOME INC IMNM 45257U108 $2.6M 0.44% 124,168 SH
44 HIMS & HERS HEALTH INC Call HIMS 433000106 $2.6M 0.43% 75,000 SH
45 AN2 THERAPEUTICS INC ANTX 037326105 $2.6M 0.42% 529,933 SH
46 SERINA THERAPEUTICS INC SER 81751A108 $1.9M 0.32% 1,000,000 SH
47 ALIGOS THERAPEUTICS INC ALGS 01626L204 $1.9M 0.31% 327,237 SH
48 IBIO INC IBIO 451033708 $1.6M 0.26% 904,268 SH
49 XILIO THERAPEUTICS INC XLO 98422T209 $1.5M 0.24% 152,464 SH
50 ARTIVION INC AORT 228903100 $1.1M 0.18% 48,481 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $604.3M 59 0001214659-26-010311
2026-03-31 2026-05-14 $697.3M 76 0001214659-26-006200
2025-12-31 2026-02-17 $635.7M 68 0001214659-26-001854
2025-09-30 2025-11-13 $395.2M 51 0001214659-25-016415
Filer Information
Address
600 THIRD AVENUE
2ND FLOOR
NEW YORK, NY 10016
Phone
(212) 601-9792
Filing Manager
Sio Capital Management, LLC
NEW YORK, NY
Signatory
Jin W. Lee
Chief Compliance Officer